Yuan Zhi
Stock Analyst at B. Riley Securities
(4.86)
# 70
Out of 4,412 analysts
17
Total ratings
56.25%
Success rate
82.45%
Average return
Main Sectors:
7 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CATX Perspective Therapeutics | Maintains: Buy | $1.2 → $1.7 | $1.58 | +7.59% | 2 | Apr 9, 2024 | |
| FUSN Fusion Pharmaceuticals | Downgrades: Neutral | $13 → $23 | $21.42 | +7.38% | 4 | Mar 20, 2024 | |
| AGEN Agenus | Maintains: Buy | $120 → $100 | $11.69 | +755.43% | 1 | Mar 18, 2024 | |
| AZTA Azenta | Maintains: Buy | $61 → $79 | $52.18 | +51.40% | 3 | Feb 1, 2024 | |
| ATNM Actinium Pharmaceuticals | Maintains: Buy | $20 → $16 | $6.87 | +132.90% | 4 | Dec 11, 2023 | |
| TNGX Tango Therapeutics | Initiates: Buy | $16 | $7.44 | +115.05% | 1 | Dec 8, 2023 | |
| CYRX Cryoport | Maintains: Buy | $30 → $22 | $16.38 | +34.31% | 2 | Jul 13, 2023 |
Perspective Therapeutics
Apr 9, 2024
Maintains: Buy
Price Target: $1.2 → $1.7
Current: $1.58
Upside: +7.59%
Fusion Pharmaceuticals
Mar 20, 2024
Downgrades: Neutral
Price Target: $13 → $23
Current: $21.42
Upside: +7.38%
Agenus
Mar 18, 2024
Maintains: Buy
Price Target: $120 → $100
Current: $11.69
Upside: +755.43%
Azenta
Feb 1, 2024
Maintains: Buy
Price Target: $61 → $79
Current: $52.18
Upside: +51.40%
Actinium Pharmaceuticals
Dec 11, 2023
Maintains: Buy
Price Target: $20 → $16
Current: $6.87
Upside: +132.90%
Tango Therapeutics
Dec 8, 2023
Initiates: Buy
Price Target: $16
Current: $7.44
Upside: +115.05%
Cryoport
Jul 13, 2023
Maintains: Buy
Price Target: $30 → $22
Current: $16.38
Upside: +34.31%